Oxford Genetics Overview

  • Founded
  • 2011
Founded
  • Status
  • Private
  • Employees
  • 71
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $3.73M
Latest Deal Amount
  • Investors
  • 5

Oxford Genetics General Information

Description

Developer biology-based technologies designed to aid in the discovery and development of biologics, cell, and gene therapies. The company's technologies specialize in DNA design, protein expression optimization, and cell line development technologies along with cloning platform and access to a library of matched plasmid inserts, enabling the bio-therapeutic industry to improve the overall efficiency through the application of synthetic biology.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Primary Office
  • Medawar Centre
  • Robert Robinson Avenue
  • Oxford OX4 4GA
  • England, United Kingdom
+44 01865 000000

Oxford Genetics Timeline

2017201820192020
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Oxford Genetics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
12. Later Stage VC 06-May-2020 $3.73M 000.00 Completed Generating Revenue
11. Later Stage VC 28-Mar-2019 00.000 000.00 000.00 Completed Generating Revenue
10. Later Stage VC 21-Aug-2017 000.00 000.00 000.00 Completed Generating Revenue
9. Grant 14-Feb-2017 00.000 00.000 Completed Generating Revenue
8. Early Stage VC 27-Oct-2016 00.000 00.000 00.000 Completed Generating Revenue
7. Early Stage VC 17-Mar-2016 00.000 00.000 00.000 Completed Generating Revenue
6. Early Stage VC 01-Dec-2015 00000 00.000 00.000 Completed Startup
5. Early Stage VC 09-Jun-2015 00000 00000 00.000 Completed Startup
4. Early Stage VC 24-Dec-2014 $313K $733K 00.000 Completed Startup
3. Early Stage VC 30-Jul-2014 $137K $420K 00.000 Completed Startup
To view Oxford Genetics’s complete valuation and funding history, request access »

Oxford Genetics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Ordinary 00,000 00.000000 0000.0 0000.0 00 0000.0 00.000
C Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
C Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
B Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
B Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.00
A Ordinary 0,000 00.000000 000.0 000.0 00 000.0 0.000
A Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 1,813 $0.013184 $58.17 $58.17 1x $58.17 1.9%
A Ordinary 3,400 $0.013184 $58.17 $58.17 1x $58.17 3.57%
To view Oxford Genetics’s complete cap table history, request access »

Oxford Genetics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer biology-based technologies designed to aid in the discovery and development of biologics, cell, and gene thera
Biotechnology
Oxford, United Kingdom
71 As of 2019
000.00
0000000000 0 000.00

0000000

amco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volu
0000000000000
London, United Kingdom
00 As of 0000
000 0000-00-00
000000&0

000000

aboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate
0000000000000
Cambridge, United Kingdom
000 As of 0000
0000
0000000 0000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Oxford Genetics Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bioline Reagents Formerly Accelerator/Incubator backed London, United Kingdom 00 000000&0
000000 Private Equity-Backed Cambridge, United Kingdom 000 0000 0000000 0000 0000
00000000 Corporation Alameda, CA 00 000000000 -
0000000 000000000 Formerly VC-backed Tianjin, China 000 00000 00000000 00000
0000 000000000000 Formerly VC-backed San Diego, CA 000 00000 00000000 00000
You’re viewing 5 of 20 competitors. Get the full list »

Oxford Genetics Executive Team (7)

Name Title Board Seat Contact Info
Ryan Cawood Ph.D Co-Founder, Chief Executive Officer & Board Member
Martin Hall Chief Financial Officer & Board Member
Jocelyne Bath Chief Operating Officer
Leonard Seymour Co-Founder, Chief Scientist & Board Member
Charles Thomas Chief Commercial Officer
You’re viewing 5 of 7 executive team members. Get the full list »

Oxford Genetics Board Members (8)

Name Representing Role Since
Barry Hames Ph.D Self Non-Executive Chairman 000 0000
Leonard Seymour Oxford Genetics Co-Founder, Chief Scientist & Board Member 000 0000
Mark Payton Ph.D Mercia Asset Management Board Member & Advisor 000 0000
Martin Hall Oxford Genetics Chief Financial Officer & Board Member 000 0000
Matthew Baker Ph.D Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »

Oxford Genetics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Oxford Genetics Investors (5)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Canaccord Genuity Investment Bank Minority 000 0000 000000 0
Invesco Asset Manager Minority 000 0000 000000 0
Innovate UK Government 000 0000 000000 0
Invesco Perpetual Asset Manager Minority 000 0000 000000 0
Mercia Asset Management Venture Capital Minority 000 0000 000000 0
To view Oxford Genetics’s complete investors history, request access »